| Biotechnology Industry | Healthcare Sector | Mr. Zhiguo Zheng CEO | SSE Exchange | CNE100002XK2 ISIN |
| CN Country | 1,174 Employees | 17 Jul 2026 Last Dividend | 12 Jul 2024 Last Split | - IPO Date |
Zhejiang Ausun Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical field, specializing in a wide range of activities that underscore its versatility and capability within the industry. Since its foundation in 2010, the company has set its sights on advancing the pharmaceutical sector through rigorous research and development, process development, as well as the manufacturing and sales of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Operating from its base in Linhai, China, Zhejiang Ausun Pharmaceutical has established itself as a crucial player, contributing significantly to the development and availability of essential pharmaceutical products and services across the globe.
Zhejiang Ausun Pharmaceutical Co., Ltd. offers a diversified portfolio of products and services tailored to meet the needs of the pharmaceutical, cosmetics, and nutritional industries. Its products and services are designed to cater to a broad spectrum of health conditions, demonstrating the company's commitment to health and well-being through innovation and quality. Below is a delineation of its primary offerings: